Emerging Carbapenem-Resistant Enterobacteriaceae Infection, Its Epidemiology and Novel Treatment Options: A Review
M Tilahun, Y Kassa, A Gedefie… - Infection and drug …, 2021 - Taylor & Francis
Infections due to multidrug-resistant Enterobacteriaceae have become major international
public health problem due to the inadequate treatment options and the historically lagged …
public health problem due to the inadequate treatment options and the historically lagged …
Present and future of carbapenem-resistant Enterobacteriaceae infections
B Suay-García, MT Pérez-Gracia - Advances in clinical …, 2021 - taylorfrancis.com
This chapter analyzes the epidemiology of Carbapenem-Resistant Enterobacteriaceae
(CRE) as well as current and future treatment options against the increasingly resistant …
(CRE) as well as current and future treatment options against the increasingly resistant …
OXA-48-like β-lactamases: global epidemiology, treatment options, and development pipeline
SE Boyd, A Holmes, R Peck… - Antimicrobial agents …, 2022 - Am Soc Microbiol
Modern medicine is threatened by the rising tide of antimicrobial resistance, especially
among Gram-negative bacteria, where resistance to β-lactams is most often mediated by β …
among Gram-negative bacteria, where resistance to β-lactams is most often mediated by β …
AmpC β-lactamase-producing Enterobacterales: what a clinician should know
Background Enterobacterales are among the most common causes of bacterial infections in
the community and among hospitalized patients, and multidrug-resistant (MDR) strains have …
the community and among hospitalized patients, and multidrug-resistant (MDR) strains have …
[HTML][HTML] Cefepime plasma concentrations and clinical toxicity: a retrospective cohort study
Objectives Cefepime remains an important antibiotic for severe bacterial infections, yet some
meta-analyses have shown elevated mortality among patients randomized to it. Therapeutic …
meta-analyses have shown elevated mortality among patients randomized to it. Therapeutic …
[HTML][HTML] 临床重要耐药菌感染传播防控策略专家共识
杨启文, 吴安华, 胡必杰, 李六亿, 刘运喜… - 中国感染控制 …, 2021 - zggrkzzz.ijournals.cn
耐药菌的传播严重威胁人类健康, 目前耐药问题日益加剧, 给医疗卫生造成极大负担.
加强耐药菌感染的预防, 控制和诊疗能力建设是医疗机构防控耐药菌感染传播的重要内容 …
加强耐药菌感染的预防, 控制和诊疗能力建设是医疗机构防控耐药菌感染传播的重要内容 …
[HTML][HTML] Antibiotic therapy strategies for treating gram-negative severe infections in the critically Ill: A narrative review
A Corona, V De Santis, A Agarossi, A Prete… - Antibiotics, 2023 - mdpi.com
Introduction: Not enough data exist to inform the optimal duration and type of antimicrobial
therapy against GN infections in critically ill patients. Methods: Narrative review based on a …
therapy against GN infections in critically ill patients. Methods: Narrative review based on a …
Infections caused by naturally AmpC-producing Enterobacteriaceae: Can we use third-generation cephalosporins? A narrative review
A Mizrahi, T Delerue, H Morel, A Le Monnier… - International journal of …, 2020 - Elsevier
The burden of antibiotic-resistant infections among Gram-negative bacteria is increasing.
Resistance to third-generation cephalosporins (3GCs) in Enterobacteriaceae is mainly …
Resistance to third-generation cephalosporins (3GCs) in Enterobacteriaceae is mainly …
In Vitro Activity of Cefepime-Enmetazobactam against Gram-Negative Isolates Collected from US and European Hospitals during 2014–2015
I Morrissey, S Magnet, S Hawser… - Antimicrobial Agents …, 2019 - Am Soc Microbiol
Enmetazobactam, formerly AAI101, is a novel penicillanic acid sulfone extended-spectrum β-
lactamase (ESBL) inhibitor. The combination of enmetazobactam with cefepime has entered …
lactamase (ESBL) inhibitor. The combination of enmetazobactam with cefepime has entered …
[HTML][HTML] Oral antibiotics in clinical development for community-acquired urinary tract infections
B Veeraraghavan, YD Bakthavatchalam… - Infectious Diseases and …, 2021 - Springer
The treatment of urinary tract infections (UTIs) has been complicated by the emergence of
multidrug-resistant, β-lactamase-expressing pathogens. As a result of the limited treatment …
multidrug-resistant, β-lactamase-expressing pathogens. As a result of the limited treatment …